Norvir and Parkinson's disease - a phase IV clinical study of FDA data

Summary:

Parkinson's disease is reported as a side effect among people who take Norvir (ritonavir), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Reyataz, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Parkinson's disease when taking Norvir. It is created by eHealthMe based on reports of 24,715 people who have side effects when taking Norvir from the FDA, and is updated regularly.

What is Norvir?

Norvir has active ingredients of ritonavir. It is often used in hiv infection. eHealthMe is studying from 24,973 Norvir users. Check the latest studies of Norvir.

What is Parkinson's disease?

Parkinson's disease is found to be associated with 1,115 drugs and 1,625 conditions by eHealthMe. Check the latest studies of Parkinson's disease.

On Jul, 19, 2026

24,715 people reported to have side effects when taking Norvir.
Among them, 12 people (0.05%) have Parkinson's disease.

Among these 12 people:

How long have people been on Norvir when they have Parkinson's disease? *

What is the gender of people who have Parkinson's disease when taking Norvir? *

female: 8.33 %
male: 91.67 %

What is the age of people who have Parkinson's disease when taking Norvir? *

What are other drugs people take besides Norvir? *

Reyataz: 6 people, 50.00%
Levothyroxine Sodium: 4 people, 33.33%
Ibuprofen: 3 people, 25.00%
Truvada: 3 people, 25.00%
Raltegravir: 3 people, 25.00%
Ramipril: 3 people, 25.00%
Nitroglycerin: 3 people, 25.00%
Pravastatin Sodium: 3 people, 25.00%
Omega-3 Marine Triglycerides: 3 people, 25.00%
Aspirin: 3 people, 25.00%

What are other side effects people have besides Parkinson's disease? *

Muscle Spasms (muscle contraction): 3 people, 25.00%
Acute Myocardial Infarction (acute heart attack): 3 people, 25.00%
Speech Impairment (Adult) (inability to speak (adult)): 2 people, 16.67%
Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 2 people, 16.67%
Confusion: 2 people, 16.67%
Neurodegenerative Disorder (progressive loss of structure or function of neurons and death of neuron): 2 people, 16.67%
Pain In Extremity: 2 people, 16.67%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 2 people, 16.67%
Angina Unstable (chest pain due to ischemia of the heart muscle- unstable): 2 people, 16.67%
Acute Kidney Failure: 2 people, 16.67%

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 8.33%
Peripheral Neuropathy (damage to nerves of the peripheral nervous system): 1 person, 8.33%
Cytomegalovirus Test Positive: 1 person, 8.33%
Chromosome Analysis Abnormal: 1 person, 8.33%
Asthma: 1 person, 8.33%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Norvir and have Parkinson's disease?

- Check whether Parkinson's disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Norvir:

Norvir (24,973 reports)

Browse all side effects of Norvir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Parkinson's disease:

Parkinson's disease (1,115 drugs)

Browse all the conditions that are associated with Parkinson's disease:

Parkinson's disease (1,625 conditions)

Related publications that referenced our studies

Woulfe JM, Gray MT, Gray DA, Munoz DG, Middeldorp JM, "Hypothesis: a role for EBV-induced molecular mimicry in Parkinson's disease", Parkinsonism & related disorders, 2014 Jul .
Woulfe JM, Gray MT, Gray DA, Munoz DG, Middeldorp JM, "Hypothesis: a role for EBV-induced molecular mimicry in Parkinson's disease", Parkinsonism & related disorders, 2014 Jul .

How the study uses the data?

The study uses data from the FDA. It is based on ritonavir (the active ingredients of Norvir) and Norvir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.